北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 药剂科  > 期刊论文
学科主题: 临床医学
题名:
Pemetrexed is Mildly Active with Good Tolerability for Treatment of Patients with Colorectal Cancer
作者: Zhang, Hui-Qing1; Lian, Chang-Hong1; Ping, Yao-Dong3; Song, Wen-Bin1; Lu, Qing-Pu; Xie, Shu-Zhe; Lin, Tao; Cheng, Lin-Zhong2
关键词: Metastatic colorectal cancer ; pemetrexed chemotherapy ; response rate
刊名: ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
发表日期: 2014
DOI: 10.7314/APJCP.2014.15.19.8391
卷: 15, 期:19, 页:8391-8394
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
关键词[WOS]: PLUS IRINOTECAN ; PHASE-II ; MULTITARGETED ANTIFOLATE ; LY231514 ; CHEMOTHERAPY ; CARCINOMA ; DISODIUM ; ENZYMES
英文摘要:

Purpose: This systematic analysis was conducted to evaluate the efficacy and safety of pemetrexed based salvage chemotherapy for treatment of patients with metastatic colorectal cancer. Methods: Clinical studies evaluating the efficacy and safety of pemetrexed based regimens on response and safety for patients with colorectal cancer were identified using a predefined search strategy. Pooled response rates (RRs) were calculated. Results: For pemetrexed based regimens, 4 clinical studies including 201 patients with advanced colorectal cancer were considered eligible for inclusion. The analysis suggested that, in all patients, pooled RR was 20.4% (41/201). Major adverse effects were neutropenia, anorexia, fatigue, and anemia. No treatment related death occurred with pemetrexed based treatment. Conclusion: This systematic analysis suggests that pemetrexed based regimens are associated with mild activity with good tolerability in treating patients with metastatic colorectal cancer.

语种: 英语
WOS记录号: WOS:000343833800058
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/66928
Appears in Collections:北京大学临床肿瘤学院_药剂科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Heping Hosp, Changzhi Med Coll, Dept Gen Surg, Changzhi, Shanxi, Peoples R China
2.Heping Hosp, Changzhi Med Coll, Dept Pharm, Changzhi, Shanxi, Peoples R China
3.Peking Univ, Dept Pharm, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China

Recommended Citation:
Zhang, Hui-Qing,Lian, Chang-Hong,Ping, Yao-Dong,et al. Pemetrexed is Mildly Active with Good Tolerability for Treatment of Patients with Colorectal Cancer[J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION,2014,15(19):8391-8394.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhang, Hui-Qing]'s Articles
[Lian, Chang-Hong]'s Articles
[Ping, Yao-Dong]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhang, Hui-Qing]‘s Articles
[Lian, Chang-Hong]‘s Articles
[Ping, Yao-Dong]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace